Skip to main content
Premium Trial:

Request an Annual Quote

Janet Lankard, Nicolas Roelofs, Joseph Sorge, Daniel Shaughnessy, Heather Kowalski, Melanie Wranaker, and Lander Brown


Janet Lankard has become vice president of sales for Quantum Dot, the company said last week. She will lead the sales team for Quantum Dot’s upcoming launch of the Mosaic Gene Expression Assay system. Lankard formerly was a director of sales for Affymetrix, which she joined in 1998. She has also been an executive sales account manager with Applied Biosystems.

Nicolas Roelofs, chief operating officer of Stratagene, will resign by the end of the year to take a position closer to his family, the company said in an SEC filing last week. Stratagene’s CEO Joseph Sorge will assume Roelofs’ responsibilities until the company finds a successor.

Daniel Shaughnessy, senior vice president of corporate development, general counsel, and corporate secretary of Charles River Laboratories, will leave his posts at the end of the year, the company said last week. He will join the faculty of Northeastern University’s College of Business Administration. Jody Acford will replace Shaughnessy in his roles. She joins Charles River Laboratories from John Hancock Financial Services, where she was senior vice president and deputy general counsel.

Heather Kowalski, Craig Venter’s long-term spokeswoman and vice president of policy and planning at the J. Craig Venter Institute, has left her post to take a position at an undisclosed public relations firm in Boston, GenomeWeb News, Pharmacogenomics Reporter’s sister publication, has learned. She was replaced by Melanie Wranaker.

Lander Brown has become vice president of human resources and administration of Third Wave Technologies, the company said on Monday. Previously, he was executive vice president of human resources and a member of the US operating board of Leo Burnett USA. Brown holds a master’s degree in human resource management from National-Louis University in Evanston, Ill., and a bachelor’s degree in social science from Michigan State University.


Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.